This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978:27 Suppl 1:235-40.

doi: 10.2337/diab.27.1.s235.

Insulin therapy in relation to circulating C-peptide levels

W Beischer, W Kerner, S Raptis, L Keller, B Beischer, E F Pfeiffer

PMID: 415925
DOI: 10.2337/diab.27.1.s235

Insulin therapy in relation to circulating C-peptide levels

W Beischer et al. Diabetes. 1978.

. 1978:27 Suppl 1:235-40.

doi: 10.2337/diab.27.1.s235.

Authors

W Beischer, W Kerner, S Raptis, L Keller, B Beischer, E F Pfeiffer

PMID: 415925
DOI: 10.2337/diab.27.1.s235

No abstract available

PubMed Disclaimer

Similar articles

[Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
Wölk I, Zilker T, Schweigart U, Ermler R, Paterek K, Bottermann P. Wölk I, et al. Verh Dtsch Ges Inn Med. 1977 Apr 17-21;83:1388-91. Verh Dtsch Ges Inn Med. 1977. PMID: 417495 German. No abstract available.
Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics.
Heding LG. Heding LG. Diabetes. 1978;27 Suppl 1:178-83. doi: 10.2337/diab.27.1.s178. Diabetes. 1978. PMID: 631439 No abstract available.
C-peptide measurement and its clinical usefulness: a review.
Bonser AM, Garcia-Webb P. Bonser AM, et al. Ann Clin Biochem. 1981 Jul;18(Pt 4):200-6. doi: 10.1177/000456328101800402. Ann Clin Biochem. 1981. PMID: 7025733 Review. No abstract available.
[Blood CPR levels in diabetes mellitus during insulin therapy, with special reference to the characteristics of PLC (proinsulin-like components) and C-peptide in fractional analysis].
Oyama H, Nakajima Y, Amagu A, Matsumura S, Nishida S. Oyama H, et al. Horumon To Rinsho. 1977 Oct;25(10):1107-12. Horumon To Rinsho. 1977. PMID: 589809 Japanese. No abstract available.
[The clinical value of C-peptide assay (author's transl)].
Vialettes B, Vague P. Vialettes B, et al. Diabete Metab. 1980 Sep;6(3):225-9. Diabete Metab. 1980. PMID: 7002655 Review. French.

See all similar articles

Cited by

Diabetic control in 102 insulin-treated out-patients.
Tchobroutsky G, Charitanski D, Blouquit Y, Papoz L, Soria J, Rosa J. Tchobroutsky G, et al. Diabetologia. 1980 Jun;18(6):447-52. doi: 10.1007/BF00261699. Diabetologia. 1980. PMID: 6998808
Postprandial 2-hr C-peptide concentration as a guide for insulin treatment in patient with NIDDM.
Kim RS, Yang IM, Kim JW, Kim YS, Kim KW, Kim SW, Choi YK. Kim RS, et al. Korean J Intern Med. 1986 Jan;1(1):120-5. doi: 10.3904/kjim.1986.1.1.120. Korean J Intern Med. 1986. PMID: 15759387 Free PMC article.
Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.
Madsbad S. Madsbad S. Diabetologia. 1983 Mar;24(3):141-7. doi: 10.1007/BF00250151. Diabetologia. 1983. PMID: 6341142 No abstract available.
The expanding clinical use of C-peptide radioimmunoassay.
Rendell M. Rendell M. Acta Diabetol Lat. 1983 Apr-Jun;20(2):105-13. doi: 10.1007/BF02624911. Acta Diabetol Lat. 1983. PMID: 6410638 Review.
Residual beta cell function in insulin-dependent diabetes: evaluation by circadian determination of C-peptide immunoreactivity.
Canivet B, Harter M, Viot G, Balarac N, Krebs BP. Canivet B, et al. J Endocrinol Invest. 1980 Apr-Jun;3(2):107-11. doi: 10.1007/BF03348235. J Endocrinol Invest. 1980. PMID: 6993546

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems